Price and states served both move. Read them off the seller's own site before you enroll.How our reviews work →

Allara Health vs altRX

Allara Health and altRX sell different medications; this is what separates them.

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

By Ruth Calder · Enforcement Editor
Editorially reviewed & fact-checked against primary sources · How we verify contentLast reviewed
Allara Health logo

Allara Health

6.1
★★★☆☆3.1/5

Best for: coaching bundled into the price rather than sold separately

Visit Allara Health →
VS
altRX logo

altRX

6.7
★★★☆☆3.4/5

Best for: semaglutide from $1149/month

Visit altRX →

If you are choosing between Allara Health and altRX, price alone will not settle it. altRX leads our six-part score, 6.7 to 6.1. One of the two has an FDA warning letter on record, covered below.

Allara Health vs altRX price

altRX publishes $149 a month. Allara Health does not post a GLP-1 price we can quote, so you would only learn its cost after an intake.

Medications and formats

AltRX lists semaglutide and tirzepatide; Allara Health does not name its drug.

On format, Allara Health posts no priced format, while altRX prices compounded injections and brand-name pens.

If you want the FDA-approved brand rather than a compounded version, altRX is the only one of the two with a brand-name price.

Where each one treats patients

Neither Allara Health nor altRX publishes the states it serves, so enter your state at the very start of each sign-up.

Pricing

Allara Health

Complete Care membership (self-pay)Brand-name
$149/mo
semaglutide

altRX

Compounded GLP-1 (semaglutide) starting tierCompounded
$149/mo
semaglutide
Compounded GLP-1/GIP (tirzepatide) starting tierCompounded
$249/mo
tirzepatide
Brand-name Ozempic®Brand-name
$1149/mo
semaglutide
Brand-name Mounjaro®Brand-name
$1249/mo
tirzepatide
Brand-name Zepbound®Brand-name
$1249/mo
tirzepatide
Brand-name Wegovy®Brand-name
$1579/mo
semaglutide

What each price covers

Both prices cover the clinician visit.

Allara Health's price also covers coaching, which altRX does not claim.

altRX's price also covers the medication itself and shipping, which Allara Health does not claim.

Allara Health is silent on shipping and lab work.

altRX is silent on lab work and coaching.

That matters most for the drug: unless Allara Health confirms otherwise, budget for medication on top of its listed price.

Allara Health

Covered by the monthly price

Medication

Charged on top

Clinician visits

In the price

Shipping

Not stated

Lab work

Not stated

Coaching

In the price

altRX

Covered by the monthly price

Medication

In the price

Clinician visits

In the price

Shipping

In the price

Lab work

Not stated

Coaching

Not stated

Where each one scores higher

Overall, altRX scores 6.7 and Allara Health 6.1 out of 10.

Allara Health is stronger on trust & safety (6.5 vs 3.5).

altRX is stronger on value (5.0 vs 3.0), effectiveness (10.0 vs 9.0) and support (7.0 vs 4.0).

User experience and accessibility are within half a point.

How we score

Allara Health

6.1/10

Overall

altRX

6.7/10

Value25%

3.0A
vs
B
5.0

Effectiveness25%

9.0A
vs
B
10.0

User Experience15%

8.0A
vs
B
8.0

Trust & Safety15%

6.5A
vs
B
3.5

Accessibility10%

5.0A
vs
B
5.0

Support10%

4.0A
vs
B
7.0

FDA warning letters

The FDA sent altRX a warning letter dated June 8, 2026 (letter 728236), and it is still open.

Allara Health has no FDA warning letter on record with us.

Features & Coverage

FeatureAllara HealthaltRX
Starting PriceNot published$149/mo
Features7 features✓8 features
States AvailableNot disclosedNot disclosed
Compounded—✓ Yes
Brand Name✓ Yes✓ Yes
FSA/HSA Accepted——
FDA Warning Letters✓None1 letter

About Allara Health

Insurance is accepted, in which case the patient owes a copay or deductible; paying cash instead costs $149/month under Complete Care, while nutrition coaching alone is $125/month. Allara Health focuses on metabolic and hormonal health in women, PCOS included, across 44 states plus DC. FDA-approved branded GLP-1s, Wegovy and Zepbound among them, can be prescribed, as can oral drugs including Metformin, Contrave and Topiramate. Dietitians work beside board-certified physicians and NPs, including endocrinologists and OB-GYNs. The company reports 45,000+ women served.

Read our full Allara Health review →

About altRX

Compounded plans open at $149 for semaglutide and $249 for tirzepatide. Branded medication runs $1,149-$1,579, a figure that already contains the consult and the shipping. Every one of the four FDA-approved brands is stocked, Mounjaro, Ozempic, Wegovy and Zepbound, which no other entry in our directory matches. altRX works in both modalities, holds LegitScript certification, and prints the FDA compounded-medication disclaimer.

Read our full altRX review →

Pros & Cons

Allara Health

What we like

  • Shows its price before the medical questionnaire, so you can compare it without handing over health information
  • The monthly price includes clinician visits and coaching
  • We found no FDA warning letters issued to Allara Health

Watch-outs

  • Not included in the monthly price: medication
  • Confirm it serves your state before you start the intake
  • Ask which pharmacy fills the prescription before you pay, so you can check its license

altRX

What we like

  • Tirzepatide costs $1249 a month, close to the $1249 median for brand-name tirzepatide across the sellers we compare
  • Shows its price before the medical questionnaire, so you can compare it without handing over health information
  • The monthly price includes the medication, clinician visits and shipping

Watch-outs

  • Semaglutide costs $1149 a month, 16% above the $990 median for brand-name semaglutide across the sellers we compare
  • Confirm it serves your state before you start the intake
  • Ask which pharmacy fills the prescription before you pay, so you can check its license
  • The FDA has issued altRX a warning letter. Read what it alleges: a letter flags a problem but does not by itself rule a seller out
  • Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality

Our Verdict

Winner: altRX

altRX wins this one, 6.7 to 6.1, above all for semaglutide from $1149/month. Allara Health fits better if coaching bundled into the price rather than sold separately is your priority.

Choose Allara Health if…

You want coaching bundled into the price rather than sold separately.

Choose altRX if…

You want semaglutide from $1149/month and an opening price near $149 a month.

Ready to start? GLP-1 providers we have vetted

Telehealth providers, vetted by us, prescribing GLP-1 online.

Vetted by our editors · no insurance required

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

8.4

Collective

Flat any-dose pricing, if you can absorb a $199 annual membership on top

8.6

Found

Tirzepatide at $169/month, 37% below the typical price

7.6

Breeze Meds

Knowing which pharmacy fills the vial: it names Belmar Pharmacy

Allara Health vs altRX: FAQ

Only altRX publishes a price ($149 a month). Allara Health quotes after sign-up.
No. Allara Health lists no named drug; altRX lists semaglutide and tirzepatide.
Allara Health does not publish where it ships; altRX does not publish where it ships. Confirm your state before paying.
Both include the clinician visit. Only Allara Health includes coaching. Only altRX includes the medication itself and shipping.
Allara Health has none. altRX has an open FDA warning letter from June 8, 2026.
No. Neither Allara Health nor altRX pays us anything.

Or see the full category ranking.

Novo Nordisk A/S owns the Wegovy®, Ozempic® and Rybelsus® marks; Eli Lilly and Company owns Mounjaro® and Zepbound®. Every other product name and mark on this page belongs to whoever owns it. No pharmaceutical manufacturer is affiliated with GLP Watchdog. See trademark disclaimer.